World Health Organization site
Skip Navigation Links
Home
Advanced Search
List ByExpand List By
Search Tips
UTNExpand UTN
ICTRP websiteExpand ICTRP website
Contact us
                   462 records for 104 trials found!
Trials are sometimes recorded in more than one registry. These records can refer to each other using the 'Secondary ID' field. The search portal uses these Secondary IDs to group records about the same trial together in the search results.
Each group of records referring to a trial is displayed in table that is seen by pressing the + symbol. The record with the earliest date of registration is always shown first.
 
 
 
 
  Showrecords per page     

1 2 3 4 5 6 7 8 9 10 Last
Recruitment statusMain ID Public TitleDate of Registration
AuthorisedEUCTR2013-002210-12-ES
Comparison of complete vs single vessel revascularization in patients with coronary artery disease.
16/12/2014
AuthorisedEUCTR2014-003033-26-HU
A clinical trial testing different doses of investigational drug ALX-0061 combined with Methotrexate to treat patients with Moderate to Severe Rheumatoid Arthritis
Recruitment statusMain IDPublic titleDate of registration
RecruitingNCT02309359A Dose-Range Finding Study for ALX-0061 Combination Therapy in Subjects With Rheumatoid Arthritis27/11/2014
26/11/2014
RecruitingNCT02380170
Epidemiology and Outcomes of Gram Negative Urosepsis
20/11/2014
RecruitingNCT02320084
Long Term Safety Study of Orfadin Treatment in HT-1 Patients in Standard Clinical Care
23/10/2014
AuthorisedEUCTR2014-001017-61-GB
A clinical trial evaluating tumour marker-driven treatment choices for advanced colorectal cancer. 18/09/2014
RecruitingNCT02195479
A Study of Combination of Daratumumab and Velcade (Bortezomib) Melphalan-Prednisone (DVMP) Compared to Velcade Melphalan-Prednisone (VMP) in Participants With Previously Untreated Multiple Myeloma 18/07/2014
RecruitingNCT02099617
Efficacy and Safety of New Generation Drug Eluting Stents Associated With an Ultra Short Duration of Dual Antiplatelet Therapy. Design of the Short Duration of Dual antiplatElet Therapy With SyNergy II Stent in Patients Older Than 75 Years Undergoing Percutaneous Coronary Revascularization.
24/03/2014
AuthorisedEUCTR2013-004392-12-SI
Efficacy and safety of semaglutide once weekly versus insulin glargine once daily as add on to metformin with or without sulphonylurea in insulin-naïve subjects with type 2 diabetes
Recruitment statusMain IDPublic titleDate of registration
AuthorisedEUCTR2013-004392-12-SKEfficacy and safety of semaglutide once weekly versus insulin glargine once daily as add on to metformin with or without sulphonylurea in insulin-naïve subjects with type 2 diabetes19/02/2014
AuthorisedEUCTR2013-004392-12-GBEfficacy and safety of semaglutide once weekly versus insulin glargine once daily as add on to metformin with or without sulphonylurea in insulin-naïve subjects with type 2 diabetes30/04/2014
AuthorisedEUCTR2013-004392-12-HREfficacy and safety of semaglutide once weekly versus insulin glargine once daily as add on to metformin with or without sulphonylurea in insulin-naïve subjects with type 2 diabetes03/09/2014
Not recruitingNCT02128932Efficacy and Safety of Semaglutide Once Weekly Versus Insulin Glargine Once Daily as add-on to Metformin With or Without Sulphonylurea in Insulin-naïve Subjects With Type 2 Diabetes24/04/2014
AuthorisedEUCTR2013-004392-12-NLEfficacy and safety of semaglutide once weekly versus insulin glargine once daily as add on to metformin with or without sulphonylurea in insulin-naïve subjects with type 2 diabetes27/05/2014
AuthorisedEUCTR2013-004392-12-ROEfficacy and safety of semaglutide once weekly versus insulin glargine once daily as add on to metformin with or without sulphonylurea in insulin-naïve subjects with type 2 diabetes30/05/2014
RecruitingCTRI/2014/09/005033A trial to evaluate the Efficacy and safety of semaglutide given once weekly versus insulin glargine given once daily as add on to metformin with or without sulphonylurea in subjects with type 2 diabetes ,who have not yet been treated with insulin.18-09-2014
13/02/2014
RecruitingISRCTN21662248
Complete versus culprit-only revascularization strategies to treat multi-vessel disease after primary percutaneous coronary interventions (PCI) for ST-segment elevation myocardial infarction
16/01/2014
AuthorisedEUCTR2013-000013-20-SI
A trial investigating the safety, tolerability, pharmacokinetics and pharmacodynamics of a single dose of long-acting growth hormone compared to daily dosing of Norditropin® SimpleXx® in children with growth hormone deficiency 20/09/2013
    
1 2 3 4 5 6 7 8 9 10 Last
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.2 - Version history